Role of Frailty in Bleeding Risk Prediction in Acute Coronary Syndrome
- Sponsor
- Assiut University
- Study ID
- NCT07158788
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Acute Coronary Syndrome
- Bleeding
- Frailty
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Studying the incremental role of frailty in predicting in-hospital, short-term (30 days), and mid-term (6 months) bleeding in ACS patients.
Key Dates
- First listed
- Sep 8, 2025
- Start date
- Oct 1, 2025
- Status verified
- Sep 2025
- Primary completion
- Mar 1, 2027
- Completion
- Sep 1, 2027
Study Design
- Enrollment
- 850 participants (estimated)
Primary Outcome Measure
Bleeding Academic Research Consortium ( BARC ) type 3 to 5 [ Time Frame: Baseline ]
Related Studies
- Safety, Efficacy of FFP From Healthy Donors to Ameliorate Frailty and Enhance Immune Function in Older IndividualsPHASE1/PHASE2 · Enrolling By Invitation · Dipnarine Maharaj · Boynton Beach, Florida
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Restarting Anticoagulation After Traumatic Intracranial HemorrhagePHASE3 · Not Yet Recruiting · University of Texas at Austin · Austin, Texas
- The Neonatal Hemorrhagic Risk Assessment in ThrombocytopeniaRecruiting · Karolinska Institutet · Boston, Massachusetts